| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |